SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: EX-4.6
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea026681201ex4-6_synergy.htm

Chunk 18 of 31
Word Count: 1377
Character Count: 8528

Document Content:

indenture executed pursuant to this Article 7 complies with the applicable provisions of this Indenture. Section 7.05 Notation on Securities in Respect of Supplemental Indentures. Securities of any series authenticated and delivered after the execution of any supplemental indenture pursuant to the provisions of this Article may bear a notation in form approved by the Trustee for such series as to any matter provided for by such supplemental indenture or as to any action taken at any such meeting. If the Issuer or the Trustee shall so determine, new Securities of any series so modified as to conform, in the opinion of the Trustee and the Board of Directors, to any modification of this Indenture contained in any such supplemental indenture may be prepared by the Issuer, authenticated by the Trustee and delivered in exchange for the Securities of such series then outstanding. ARTICLE 8 CONSOLIDATION, MERGER, SALE OR CONVEYANCE

Section 8.01 Issuer May
Consolidate, etc., on Certain Terms. The Issuer covenants that it will not merge or consolidate with any other Person or sell, convey,
transfer, lease or otherwise dispose of all or substantially all of its property and assets to any Person (other than a consolidation
with or merger with or into or a sale, conveyance, transfer, lease or other disposition to a Wholly-Owned Subsidiary with a positive net
worth; provided that, in connection with any such merger of the Issuer with a Wholly-Owned Subsidiary, no consideration (other
than common stock) in the surviving person or the Issuer shall be issued or distributed to the stockholders of the Issuer), unless (i)
either (x) the Issuer shall be the continuing corporation, or the successor corporation or (y) the Person formed by such consolidation
or into which the Issuer is merged or that acquires by sale or conveyance substantially all the assets of the Issuer (if other than the
Issuer) shall be a corporation or limited liability company organized and validly existing under the laws of the United States of America
or any jurisdiction thereof and shall expressly assume the due and punctual payment of the Principal of and interest on all the Securities,
according to their tenor, and the due and punctual performance and observance of all of the covenants and conditions
of this Indenture to be performed or observed by the Issuer, by supplemental indenture satisfactory to the Trustee, executed and delivered
to the Trustee by such Person, (ii) immediately after giving effect to such transaction, no default or Event of Default shall have occurred
and be continuing and (iii) the Issuer delivers to the Trustee an Officers’ Certificate and Opinion of Counsel, in each case stating
that such consolidation, merger or transfer and such supplemental indenture complies with this Section 8.01 and that all conditions precedent
provided for herein relating to such transaction have been complied with; provided, however, that the foregoing limitations shall
not apply if, in the good faith determination of the Board of Directors, whose determination shall be evidenced by a board resolution
certified to the Trustee, the principal purpose of such transaction is to change the state of incorporation of the Issuer; and provided
further that any such transaction shall not have as one of its purposes the evasion of the foregoing limitations.

Section 8.02 Successor
Corporation Substituted. In case of any such consolidation, merger, sale, conveyance, transfer, lease or other disposition, and following
such an assumption by the successor Person, such successor Person shall succeed to and be substituted for the Issuer, with the same effect
as if it had been named herein. Such successor Person may cause to be signed, and may issue either in its own name or in the name of the
Issuer prior to such succession any or all of the Securities issuable hereunder which theretofore shall not have been signed by the Issuer
and delivered to the Trustee; and, upon the order of such successor Person instead of the Issuer and subject to all the terms, conditions
and limitations in this Indenture prescribed, the Trustee, pursuant to the terms hereof, shall authenticate and shall deliver any Securities
which previously shall have been signed and delivered by the officers of the Issuer to the Trustee for authentication, and any Securities
which such successor Person thereafter shall cause to be signed and delivered to the Trustee for that purpose. All of the Securities so
issued shall in all respects have the same legal rank and benefit under this Indenture as the Securities theretofore or thereafter issued
in accordance with the terms of this Indenture as though all of such Securities had been issued at the date of the execution hereof.

In case of any such consolidation,
merger, sale, conveyance, transfer, lease or other disposition, such changes in phraseology and form (but not in substance) may be made
in the Securities thereafter to be issued as may be appropriate.

Upon the assumption by the
successor Person in the manner described in this Article, the Issuer shall be discharged from all obligations and covenants under this
Indenture and the Securities.

ARTICLE 9

DISCHARGE OF INDENTURE

Section 9.01 Defeasance
Within One Year of Payment. Except as otherwise provided in this Section 9.01, the Issuer may terminate its obligations under the
Securities of any series and this Indenture with respect to Securities of such series if:

(i) all Securities of such series previously
authenticated and delivered (other than destroyed, lost or wrongfully taken Securities of such series that have been replaced or Securities
of such series for whose payment money or securities have theretofore been held in trust and thereafter repaid to the Issuer, as provided
in Section 9.05) have been delivered to the Trustee for cancellation and the Issuer has paid all sums payable by it hereunder; or

(ii) (A) the Securities of such series
mature within one year or all of them are to be called for redemption within one year under arrangements satisfactory to the Trustee for
giving the notice of redemption, (B) the Issuer irrevocably deposits in trust with the Trustee, as trust funds solely for the benefit
of the Holders of such Securities for that purpose, money or U.S. Government Obligations or a combination thereof sufficient (unless such
funds consist solely of money, in the opinion of a nationally recognized firm of independent public accountants expressed in a written
certification thereof delivered to the Trustee), without consideration of any reinvestment and after payment of all Federal, state and
local taxes or other charges and assessments in respect thereof payable by the Trustee, to pay Principal of and interest on the Securities
of such series to maturity or redemption, as the case may be, and to pay all other sums payable by it hereunder and (C) the Issuer delivers
to the Trustee an Officers’ Certificate and an Opinion of Counsel, in each case stating that all conditions
precedent provided for herein relating to the satisfaction and discharge of this Indenture with respect to the Securities of such series
have been complied with.

With respect to the foregoing
clause (i), only the Issuer’s obligations under Sections 5.06 and 9.05 in respect of the Securities of such series shall survive.
With respect to the foregoing clause (ii), only the Issuer’s obligations in Sections 2.03 through 2.11, 3.02, 5.06, 5.09 and 9.05
in respect of the Securities of such series shall survive until such Securities of such series are no longer outstanding. Thereafter,
only the Issuer’s obligations in Sections 5.06 and 9.05 in respect of the Securities of such series shall survive. After any such
irrevocable deposit, the Trustee shall acknowledge in writing the discharge of the Issuer’s obligations under the Securities of
such series and this Indenture with respect to the Securities of such series except for those surviving obligations specified above.

Section 9.02 Defeasance.
Except as provided below, the Issuer will be deemed to have paid and will be discharged from any and all obligations in respect of the
Securities of any series and the provisions of this Indenture will no longer be in effect with respect to the Securities of such series
(and the Trustee, at the expense of the Issuer, shall execute instruments in form and substance satisfactory to the Issuer and the Trustee
acknowledging the same) if the following conditions shall have been satisfied: